That's a wrap.
Market opens Friday, Nov 13 at 9:30 AM ET
8:00 AMYahoo Finance
Five presentations, one leading innovation: Humacyte’s Acellular Tissue Engineered Vessel takes Center Stage at VEITH 2026
5:04 PMYahoo Finance
Humacyte (HUMA) Q3 2026 earnings call transcript
4:59 PMYahoo Finance
Humacyte, Inc. Q3 2026 earnings call summary
12:15 PMYahoo Finance
Humacyte Q3 earnings call highlights
7:15 AMYahoo Finance
Humacyte, Inc. (HUMA) reports Q3 loss, tops revenue estimates
7:00 AMYahoo Finance
Humacyte reports third quarter 2026 results, highlighted by more than Doubling Symvess revenue and Expanding Commercial adoption
Humacyte highlights first-in-Human Coronary Bypass Study at American Heart Association Scientific sessions 2026
5:00 PMYahoo Finance
Humacyte, Inc. (HUMA) Registers a bigger fall than the market: Important facts to Note
Humacyte Innovative Research in Coronary Bypass and vascular regeneration to be highlighted at American Heart Association Scientific sessions 2026
Humacyte, Inc. (HUMA) Suffers a larger drop than the General market: Key Insights
Humacyte Strengthens Intellectual Property Portfolio with Issuance of new U.S. Patent Covering Symvess and other Bioengineered Tissues